版本:
中国

BRIEF-CRISPR Therapeutics announces patent for CRISPR/CAS genome editing in china

June 19 CRISPR Therapeutics AG:

* CRISPR Therapeutics announces patent for CRISPR/CAS genome editing in China

* CRISPR Therapeutics AG - China's state intellectual property office granted a patent broadly covering CRISPR's in-licensed gene editing technology Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐